CanDL database shines light on clinically important cancer gene mutations
Many clinical trials use genome sequencing to learn which gene mutations are present in a patient's tumor cells. The question is important because targeting the right mutations with the right drugs can stop cancer in its ...
Aug 27, 2015
0
7